医疗设备公司Bionano Genomics(BNGO)今日盘中股价出现大幅下跌,引发市场高度关注。截至午间收盘,该股下跌5.02%,报4.14美元,成交量和振幅均较大。
分析人士指出,该公司最新公布的财报显示营收和净利润数据令人失望,或是导致股价大跌的主要原因之一。财报显示,Bionano上季度营收仅6.07百万美元,净亏损达4425万美元,大幅超出预期。每股收益为-30.92美元,毛利更是出现845万美元的亏损。
另一影响因素是机构对该股预期观望。分析显示,参与评级的2家机构中,全部给予持有评级,无买入或卖出建议,反映出对公司前景并不太乐观。与此同时,该股所在医疗设备行业今日整体涨幅不足0.2%,行业表现平平,也可能加剧了Bionano Genomics股价承压的局面。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.